Compare GRFS & VCTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GRFS | VCTR |
|---|---|---|
| Founded | 1940 | 2013 |
| Country | Spain | United States |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 6.1B |
| IPO Year | N/A | 2018 |
| Metric | GRFS | VCTR |
|---|---|---|
| Price | $7.87 | $99.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $10.15 | ★ $74.44 |
| AVG Volume (30 Days) | ★ 720.6K | 411.8K |
| Earning Date | 07-28-2022 | 05-06-2026 |
| Dividend Yield | 1.80% | ★ 2.60% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.33 |
| Revenue | N/A | ★ $413,412,000.00 |
| Revenue This Year | $4.49 | $17.68 |
| Revenue Next Year | $6.42 | $5.92 |
| P/E Ratio | ★ $18.67 | $74.11 |
| Revenue Growth | N/A | ★ 0.92 |
| 52 Week Low | $6.96 | $57.03 |
| 52 Week High | $10.88 | $102.05 |
| Indicator | GRFS | VCTR |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 61.72 |
| Support Level | $7.45 | $82.27 |
| Resistance Level | $8.35 | $102.05 |
| Average True Range (ATR) | 0.19 | 2.86 |
| MACD | 0.07 | -0.14 |
| Stochastic Oscillator | 55.47 | 63.04 |
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
Victory Capital Holdings Inc is a diversified investment management firm. The company provides specialized investment strategies to institutions, intermediaries, retirement platforms and individual investors. Its offerings include actively and passively managed mutual funds, rules-based and active exchange traded funds (ETFs), institutional separate accounts, variable insurance products (VIPs), alternative investments, private closed end funds, and a 529 Education Savings Plan. The company operates in one operating and reportable segment that provides investment management services and products to institutional, intermediary, retirement platforms and individual investors. The majority of the company's revenue consists of Investment management fees.